Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. Commentary.
Forbes
Thomas L
TL
D000671:Amputation, Surgical; D016026:Bone Marrow Transplantation; D016638:Critical Illness; D004311:Double-Blind Method; D042783:Endothelial Cells / Q000637:transplantation*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007511:Ischemia / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D023821:Limb Salvage; D035002:Lower Extremity / Q000098:blood supply*; D018919:Neovascularization, Physiologic; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D033581:Stem Cell Transplantation; D013997:Time Factors; D014182:Transplantation, Autologous; D016896:Treatment Outcome